PHA SCIENTIFIC LEADERSHIP COUNCIL 2018-08-13T18:59:48+00:00

PHA Scientific Leadership  Council

PHA’s Scientific Leadership Council (SLC) is composed of 28 leaders in the field of pulmonary hypertension. Coordinating the medical arm of PHA, they provide medical and scientific leadership and guidance for the mission of the Pulmonary Hypertension Association and lead the development of the wide array of all PHA’s medical programming.

SLC members proactively facilitate the development of new knowledge about pulmonary hypertension, develop educational resources for medical and public audiences and advocate to raise awareness about pulmonary hypertension. The SLC was formed out of the PHA philosophy that patients and medical professionals can achieve more working together.

Members of the SLC are clinicians, research scientists and nurses in medical centers recognized for performing outstanding research and providing excellent care for patients with pulmonary hypertension.

Members of the Scientific Leadership Council (SLC) serve as PHA’s leadership and are cardiologists, pulmonologists and rheumatologists – leading PH experts that branch out into all areas of scientific exploration and treatment of pulmonary hypertension. Not only do they guide the vast array of medical education PHA offers to both the medical and patient communities, they also are involved in the development of cutting edge research exploring various aspects of PH such as the implications of genetics in pulmonary hypertension, treatments for children living with PH, PH and associated diseases and much more.

Many past and present members of the SLC were involved in the creation of the Expert Consensus Document on Pulmonary Hypertension, lead in the development of the Journal Advances in Pulmonary Hypertension and the comprehensive treatment fact sheets and consensus statements available as resources on our website.

PHA Scientific Leadership Council Members

Ronald J. Oudiz, MDSLC, Chair
Ronald J. Oudiz, MD
Professor of Medicine
Director, Liu Center for Pulmonary Hypertension
LA Biomedical Research Institute at Harbor – UCLA Medical Center
Torrance, CA
Term Ends June 2022

Erika S. Berman Rosenzweig, MDSLC, Immediate Past Chair
Erika S. Berman Rosenzweig, MD

Professor of Pediatrics (in Medicine)
Columbia University Medical Center – New York Presbyterian Hospital
New York, NY
Term Ends June 2020

Murali M. Chakinala, MDSLC, Chair Elect
Murali M. Chakinala, MD, FCCP

Associate Professor
Washington University School of Medicine
Division of Pulmonary and Critical Care
St. Louis, MO
Term Ends June 2020

Committee Chairs

Todd M. Bull, MD
Chair, Research Committee
Associate Professor in Medicine
Medical Director, Anschutz Intensive Care Unit
University of Colorado Hospital
Denver, CO

Roberto F. Machado, MD
Chair, PHA Medical Education On-Demand Program Planning Committee
Dr. Calvin H. English Professor of Medicine
Chief, Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine
Indiana University Department of Medicine
Indianapolis, IN

Michael A. Mathier, MD
Chair, PHA Online University Committee
Assistant Professor of Medicine
Director of Pulmonary Hypertension Program
University of Pittsburgh Medical Center
Pittsburgh, PA

Harrison Farber, MD
Editor-In-Chief, Advances in Pulmonary Hypertension
Professor of Medicine
Director, Pulmonary Hypertension Center
Boston University/Boston Medical Center
Boston, Massachusetts

Stephen C. Mathai, MD, MHS
Chair, PHA Preceptorship Program Planning Committee
Associate Professor of Medicine
Johns Hopkins University
Baltimore, MD

Mardi Gomberg-Maitland, MD, MSc
Chair, Education Committee
Director of RV Failure, HFpEF, and Cardio-Oncology Programs
Co-Director of the Pulmonary Vascular Disease Program
Inova Heart and Vascular Institute
Falls Church, VA

 

Members

Steven H. Abman, MD
Professor, Department of Pediatrics
Director, Pediatric Heart Lung Center
University of Colorado School of Medicine
Children’s Hospital Colorado
Aurora, CO
Term Ends June 2020

William R. Auger, MD
Professor of Clinical Medicine
Administrative Director, Pulmonary PTE Program
UCSD Medical Center
La Jolla, CA
Term Ends June 2020

Sonja Bartolome, MD
Associate Professor, Internal Medicine
Director, Liver Transplant Critical Care
University of Texas Southwestern Medical Center
Dallas, TX
Term ends June 2021

Todd M. Bull, MD
Associate Professor of Medicine
University of Colorado
Denver, CO
Term Ends June 2020

Kelly Chin, MD
Associate Professor, Internal Medicine
Director, Pulmonary Hypertension Program
UT Southwestern Medical Center
Dallas, TX
Term Ends June 2020

Lorinda Chung, MD
Assistant Professor of Medicine
Stanford University
Palo Alto, CA
Term Ends June 2020

Vinicio A. de Jesus Perez, MD, FCCP, FAHA
Assistant Professor in Medicine
Wall Center Adult PH Clinic
Division of Pulmonary and Critical Care Medicine
Stanford University Medical Center
Stanford, CA
Terms ends June 2021

Ankit A. Desai, MD, FACC, FAHA

Jeffrey Fineman, MD
Pediatric Critical Care Specialist
Criterial Care Division Chief
University of California, San Francisco
Benioff Children’s Hospital
San Francisco
Term ends June 2021

Robert P. Frantz, MD
Director, Pulmonary Hypertension Clinic
Professor of Medicine
Mayo Clinic
Rochester, MN
Term Ends June 2021

Mardi Gomberg-Maitland, MD, MSc
Director of RV Failure, HFpEF, and Cardio-Oncology Programs
Co-Director of the Pulmonary Vascular Disease Program
Inova Heart and Vascular Institute
Falls Church, VA
Term Ends June 2019

Anna Hemnes, MD
Associate Professor of Medicine
Assistant Director, Pulmonary Vascular Center
Vanderbilt University
Nashville, TN
Term Ends June 2019

Steven Kawut, MD, MS
Professor of Medicine and Epidemiology
Director, Pulmonary Vascular Disease Program
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA
Term Ends June 2019

Tim Lahm, MD
Associate Professor of Medicine and Cellular & Integrative Physiology
Division of Pulmonary, Critical Care, Sleep and Occupational Medicine
Indiana University School of Medicine
Indianapolis, IN
Term Ends June 2020

Deborah J. Levine, MD
Director of Pulmonary Hypertension Clinic
Medical Director of Inpatient and Outpatient Lung Transplantation
San Antonio, Texas
Term ends June 2021

Roberto F. Machado, MD
Dr. Calvin H. English Professor of Medicine
Chief, Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine
Indiana University Department of Medicine
Indianapolis, IN
Term Ends June 2020

Stephen C. Mathai, MD, MHS
Associate Professor of Medicine
Johns Hopkins University
Baltimore, MD
Term Ends June 2019

Michael A. Mathier, MD
Assistant Professor of Medicine
Director of Pulmonary Hypertension Program
University of Pittsburgh Medical Center
Pittsburgh, PA
Term Ends June 2018

John H. Newman, MD
Vanderbilt University School of Medicine
T1218 Vanderbilt Medical Center North
Nashville, TN
Term Ends June 2018

John Ryan, MD
Director, Pulmonary Hypertension Center
University of Utah
Salt Lake City, UT
Term ends June 2021

Jeffrey S. Sager, MD, MSCE
Director, Cottage Pulmonary Hypertension Center
Santa Barbara Pulmonary Consultants
Santa Barbara, CA
Term Ends June 2019

Oksana A. Shlobin, MD, FCCP
Co-Director, Pulmonary Vascular Disease Program
Director of Education, Advanced Lung Disease and Transplant Program
Inova Fairfax Hospital
Falls Church, VA
Term Ends June 2020

Thenappan Thenappan, MD
Associate Professor of Medicine, Cardiovascular Division
University of Minnesota
Minneapolis, MN
Term ends June 2021

Corey E. Ventetuolo, MD, MS
Assistant Professor of Medicine and Health Services, Policy, and Practice, The Warren Alpert Medical School of Brown University
Associate Director, Pulmonary Hypertension Center
Medical Director, Adult Extracorporeal Life Support Program
Director of Clinical Research, Pulmonary Division
Rhode Island Hospital
Providence, RI
Terms ends June 2021

Timothy L. Williamson, MD
Associate Professor of Medicine
Director, Center for Pulmonary Arterial Hypertension
University of Kansas Medical Center
Kansas City, KS
Term Ends June 2020

Joel A. Wirth, MD
Clinical Associate Professor of Medicine
University of Vermont
Division Director, Pulmonary & Critical Care Medicine
Maine Medical Center
Term Ends June 2019

Delphine Yung, MD
Associate Professor
Center for Clinical and Translational Research
Seattle Children’s Hospital
Seattle, WA
Term Ends June 2019

Liasons

Cheri Abbott, RN
PH Professional Network Liaison
Chair-Elect, PH Professional Network
University of Colorado School of Medicine
Denver, CO
Terms Ends June 2022

Rita Orth, RN
Patient Liaison
PHA Board Member

Fran Rogers, MSN, CRNP
PH Professional Network Liaison
Chair-Elect, PH Professional Network
Temple University Hospital
Philadelphia, PA
Term Ends June 2020

SLC Distinguished Advisory Committee

David B. Badesch, MD
Professor of Medicine
Clinical Director, Pulmonary Hypertension Center
University of Colorado Health Sciences Center
Aurora, CO

Bruce Brundage, MD
Professor of Medicine Emeritus
David Geffen School of Medicine at UCLA
Bend, OR

Richard N. Channick, MD
Associate Professor of Medicine
Harvard Medical School
Director, Pulmonary Hypertension Program
Massachusetts General Hospital
Boston, MA

C. Gregory Elliott, MD
Professor of Medicine
University of Utah School of Medicine
Murray, UT

Karen Fagan, MD
Chief of Pulmonology, Critical Care
Professor of Internal Medicine and Pharmacology
University of South Alabama
Mobile, AL

Michael D. McGoon, MD
Professor Emeritus of Medicine
Mayo Clinic
Rochester, MN

Vallerie V. McLaughlin, MD
Director, Pulmonary Hypertension Program
Kim A. Eagle, MD, Endowed Professor in Cardiovascular Medicine
University of Michigan CVC Cardiovascular Medicine
Ann Arbor, MI